Browse diseases

…ork for standardised TSR assessment and prognosis prediction in hepatocellular carcinoma (HCC).Design We integrated whole-slide image (WSI) data with cl…

…d by reprogramming of the myeloid cells. Among 17 patients with HCC, one durable complete response was observed, and 10 (59%) patie…

…ing an elevated FIB-4, identified patient subgroups with annual hepatocellular carcinoma (HCC) incidence ≥1%, justifying surveillance in these groups.1 …

…hronic hepatitis B (CHB) remains a major cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide, affecting over 250 million people. In the UK, …

… in order to reduce the risk of liver-related complications and hepatocellular carcinoma (HCC). The aim of this study is to assess the cost-effectivenes…

…gaining traction as a robust treatment option for patients with hepatocellular cancer (HCC) across all cancer stages. RE allows the delivery of targe…

…vation of metabolic reprogramming promotes tumor progression in hepatocellular carcinoma. Cell Metab. 2023;35:1183–1199.e6.Guo J, Liu Z, Zhang X, et al.…

…allele. The top mutated genes were TP53 (71%) and APC (63%) for CRC, TP53 (76%) and CDKN2A (28%) for PDAC, GNAS (34%) and TP53 (34%…

…nd Hepatocellular carcinoma (HCC) is the most prevalent type of liver cancer. Incidence of HCC has increased over the past several decades, …

…Introduction Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality wo…

…n (ICI) has become a first-line treatment strategy for advanced hepatocellular carcinoma (HCC). However, treatment efficacy remains varied, and there ar…

…logy commissioned an update on the guidelines for management of hepatocellular carcinoma (HCC) in adults at an opportune time. The incidence of and mort…